TRxADE HEALTH, INC. Files 8-K: Board and Officer Changes
Ticker: SCNX · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Trxade Health, Inc (SCNX) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, governance, filing
TL;DR
TRxADE HEALTH board/exec changes filed. New directors elected, exec comp detailed.
AI Summary
On June 17, 2024, TRxADE HEALTH, INC. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on the election of new directors and the appointment of certain officers, along with details regarding compensatory arrangements for these individuals. The report also covers financial statements and exhibits.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- TRxADE HEALTH, INC. (company) — Registrant
- June 17, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39199 (commission_file_number) — SEC File Number
FAQ
What specific changes were made to the board of directors and executive officers?
The filing indicates the election of new directors and the appointment of certain officers, though specific names are not detailed in the provided excerpt.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 17, 2024.
What is the state of incorporation for TRxADE HEALTH, INC.?
TRxADE HEALTH, INC. is incorporated in Delaware.
What is the SEC file number for TRxADE HEALTH, INC.?
The SEC file number for TRxADE HEALTH, INC. is 001-39199.
What items are covered by this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, and financial statements and exhibits.
Filing Stats: 765 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-06-20 08:00:24
Key Financial Figures
- $0.00001 — ch registered Common stock, par value $0.00001 per share MEDS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 41KB
- 0001493152-24-024424.txt ( ) — 212KB
- meds-20240617.xsd (EX-101.SCH) — 3KB
- meds-20240617_lab.xml (EX-101.LAB) — 33KB
- meds-20240617_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRxADE HEALTH, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: June 20, 2024